Exodus Point Capital Management, LP Hepion Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.93 - $1.29 $22,506 - $31,218	-24,200 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.14 - $1.58 $14,452 - $20,031	-12,678 Reduced 34.38%	24,200 $28,000
Q3 2021 Nov 15, 2021	BUY	$1.39 - $2.1 $20,438 - $30,878	14,704 Added 66.31%	36,878 $56,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.26 $34,591 - $50,113	22,174 New	22,174 $44,000
Q4 2020 Feb 16, 2021	SELL	$1.58 - $3.64 $18,378 - $42,340	-11,632 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.84 - $4.59 $33,034 - $53,390	11,632 New	11,632 $36,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.